Around the world, the communities most underserved by health systems have been among the hardest hit by the COVID-19 pandemic.1 Often, these are the same groups that are disproportionally affected by viral hepatitis. With just 10 years to achieve WHO’s target, adopted in 2016, to eliminate hepatitis by 2030,2 has the COVID-19 pandemic put reaching that goal in greater doubt?
A new study suggests that certain dietary changes may be more effective than medication.
Both a special diet that excludes “FODMAP” compounds and a low-carb high-fibre diet were effective
Two 4-week dietary interventions and optimised medical treatment reduced the severity of IBS symptoms, with a larger effect size in the diet groups. Dietary interventions…
Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension…
Although the past 10 years have brought a wave of novel medications and mechanisms to the management of Crohn’s disease and inflammatory bowel disease (IBD),…
Only around a third of patients with active luminal Crohn’s disease treated with an anti-TNF drug were in remission at the end of 3 years…
The gut microbiome plays an important part in a number of gastrointestinal conditions, including Clostridioides difficile infection and inflammatory bowel disease. Interest in modulating the…
Ireland will require them starting in 2026, and there are nascent efforts elsewhere to add more explicit labeling about the health risks of drinking.
For patients with distal pancreatectomy, a no-drain policy is noninferior in terms of major morbidity, according to a study published online.
Chronic hepatitis B virus (HBV) infection is a major public health problem and cause of chronic liver disease and led to an estimated 1·1 million…
